Loading…

Letter: Helicobacter pylori‐related non‐alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia – authors' reply

Linked ContentThis article is linked to Ahn et al, and Kountouras et al papers. To view these articles visit https://doi.org/10.1111/apt.13866 and https://doi.org/10.1111/apt.13900.

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2017-02, Vol.45 (4), p.577-578
Main Authors: Ahn, J. S., Sinn, D. H., Son, H. J., Gwak, G.‐Y.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3481-20918a2149ac402c5545fa198575a1fdc3b12f169841a7ba2e523d308abb26273
container_end_page 578
container_issue 4
container_start_page 577
container_title Alimentary pharmacology & therapeutics
container_volume 45
creator Ahn, J. S.
Sinn, D. H.
Son, H. J.
Gwak, G.‐Y.
description Linked ContentThis article is linked to Ahn et al, and Kountouras et al papers. To view these articles visit https://doi.org/10.1111/apt.13866 and https://doi.org/10.1111/apt.13900.
doi_str_mv 10.1111/apt.13911
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1857752820</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1922445061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3481-20918a2149ac402c5545fa198575a1fdc3b12f169841a7ba2e523d308abb26273</originalsourceid><addsrcrecordid>eNp1kc9qFTEUh4NY7PXqwheQgAvt4rY5mcn86a4UbYULuqjr4UzmDDc1MxmTjGV2fQTBl_C5-iTG3tqFYCCEA1--nJwfY69AHENaJzjFY8hqgCdsBVmhNlJkxVO2ErKoN7KC7JA9D-FaCFGUQj5jh7ISZa6EWrFfW4qR_Cm_JGu0a1Gnik-Ldd7c3f7wZDFSx0c3pgqtdjuXON5jjAu35nuCOxMIA_EbE3dcu1G7wUQcIx8oYnuPh2XsvBuIY-DehK_pvo7O8z5t7dJbpCNaPpKbLAaD_O72J8c57pwPb7mnyS4v2EGPNtDLh3PNvnx4f3V-udl-uvh4frbd6CyvIP28hgol5DXqXEitVK56hLpSpULoO521IHso6ioHLFuUpGTWZaLCtpWFLLM1e7f3Tt59mynEZjBBk7WYuptDA8lUKlmlEa_Zm3_Qazf7MXXXQC1lniZcQKKO9pT2LgRPfTN5M6BfGhDNn_iaFF9zH19iXz8Y53ag7pH8m1cCTvbAjbG0_N_UnH2-2it_AyrNqVo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1922445061</pqid></control><display><type>article</type><title>Letter: Helicobacter pylori‐related non‐alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia – authors' reply</title><source>Wiley</source><creator>Ahn, J. S. ; Sinn, D. H. ; Son, H. J. ; Gwak, G.‐Y.</creator><creatorcontrib>Ahn, J. S. ; Sinn, D. H. ; Son, H. J. ; Gwak, G.‐Y.</creatorcontrib><description>Linked ContentThis article is linked to Ahn et al, and Kountouras et al papers. To view these articles visit https://doi.org/10.1111/apt.13866 and https://doi.org/10.1111/apt.13900.</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.13911</identifier><identifier>PMID: 28074505</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Fatty liver ; Health risks ; Liver ; Liver diseases ; Metabolic disorders ; Metabolic syndrome ; Risk factors</subject><ispartof>Alimentary pharmacology &amp; therapeutics, 2017-02, Vol.45 (4), p.577-578</ispartof><rights>2017 John Wiley &amp; Sons Ltd</rights><rights>Copyright © 2017 John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3481-20918a2149ac402c5545fa198575a1fdc3b12f169841a7ba2e523d308abb26273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28074505$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahn, J. S.</creatorcontrib><creatorcontrib>Sinn, D. H.</creatorcontrib><creatorcontrib>Son, H. J.</creatorcontrib><creatorcontrib>Gwak, G.‐Y.</creatorcontrib><title>Letter: Helicobacter pylori‐related non‐alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia – authors' reply</title><title>Alimentary pharmacology &amp; therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Linked ContentThis article is linked to Ahn et al, and Kountouras et al papers. To view these articles visit https://doi.org/10.1111/apt.13866 and https://doi.org/10.1111/apt.13900.</description><subject>Fatty liver</subject><subject>Health risks</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Metabolic disorders</subject><subject>Metabolic syndrome</subject><subject>Risk factors</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kc9qFTEUh4NY7PXqwheQgAvt4rY5mcn86a4UbYULuqjr4UzmDDc1MxmTjGV2fQTBl_C5-iTG3tqFYCCEA1--nJwfY69AHENaJzjFY8hqgCdsBVmhNlJkxVO2ErKoN7KC7JA9D-FaCFGUQj5jh7ISZa6EWrFfW4qR_Cm_JGu0a1Gnik-Ldd7c3f7wZDFSx0c3pgqtdjuXON5jjAu35nuCOxMIA_EbE3dcu1G7wUQcIx8oYnuPh2XsvBuIY-DehK_pvo7O8z5t7dJbpCNaPpKbLAaD_O72J8c57pwPb7mnyS4v2EGPNtDLh3PNvnx4f3V-udl-uvh4frbd6CyvIP28hgol5DXqXEitVK56hLpSpULoO521IHso6ioHLFuUpGTWZaLCtpWFLLM1e7f3Tt59mynEZjBBk7WYuptDA8lUKlmlEa_Zm3_Qazf7MXXXQC1lniZcQKKO9pT2LgRPfTN5M6BfGhDNn_iaFF9zH19iXz8Y53ag7pH8m1cCTvbAjbG0_N_UnH2-2it_AyrNqVo</recordid><startdate>201702</startdate><enddate>201702</enddate><creator>Ahn, J. S.</creator><creator>Sinn, D. H.</creator><creator>Son, H. J.</creator><creator>Gwak, G.‐Y.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201702</creationdate><title>Letter: Helicobacter pylori‐related non‐alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia – authors' reply</title><author>Ahn, J. S. ; Sinn, D. H. ; Son, H. J. ; Gwak, G.‐Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3481-20918a2149ac402c5545fa198575a1fdc3b12f169841a7ba2e523d308abb26273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Fatty liver</topic><topic>Health risks</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Metabolic disorders</topic><topic>Metabolic syndrome</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahn, J. S.</creatorcontrib><creatorcontrib>Sinn, D. H.</creatorcontrib><creatorcontrib>Son, H. J.</creatorcontrib><creatorcontrib>Gwak, G.‐Y.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahn, J. S.</au><au>Sinn, D. H.</au><au>Son, H. J.</au><au>Gwak, G.‐Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Letter: Helicobacter pylori‐related non‐alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia – authors' reply</atitle><jtitle>Alimentary pharmacology &amp; therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2017-02</date><risdate>2017</risdate><volume>45</volume><issue>4</issue><spage>577</spage><epage>578</epage><pages>577-578</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>Linked ContentThis article is linked to Ahn et al, and Kountouras et al papers. To view these articles visit https://doi.org/10.1111/apt.13866 and https://doi.org/10.1111/apt.13900.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28074505</pmid><doi>10.1111/apt.13911</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0269-2813
ispartof Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (4), p.577-578
issn 0269-2813
1365-2036
language eng
recordid cdi_proquest_miscellaneous_1857752820
source Wiley
subjects Fatty liver
Health risks
Liver
Liver diseases
Metabolic disorders
Metabolic syndrome
Risk factors
title Letter: Helicobacter pylori‐related non‐alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia – authors' reply
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A15%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Letter:%20Helicobacter%20pylori%E2%80%90related%20non%E2%80%90alcoholic%20fatty%20liver%20disease%20with%20concomitant%20metabolic%20syndrome%20as%20risk%20factor%20for%20colorectal%20neoplasia%20%E2%80%93%20authors'%20reply&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Ahn,%20J.%20S.&rft.date=2017-02&rft.volume=45&rft.issue=4&rft.spage=577&rft.epage=578&rft.pages=577-578&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.13911&rft_dat=%3Cproquest_cross%3E1922445061%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3481-20918a2149ac402c5545fa198575a1fdc3b12f169841a7ba2e523d308abb26273%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1922445061&rft_id=info:pmid/28074505&rfr_iscdi=true